Patent · US Expired

Method and composition for the treatment of mammalian HIV infection

US5770688A · kind A · utility

0Cited by

1References

10Claims

0Family size

Assignee

GSF FORSCHUNGSZENTRUM FUR UMWELT UND GESUNDHEIT GMBH · DE

Inventors

Torben Saermark · Malmö, SE
Volker Erfle · Munich, DE

Key dates

Filing date	Jun 6, 1995
Grant date	Jun 23, 1998
Priority date	—
Expiry date	Jun 6, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/17
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method and composition are described for the treatment of mammalian HIV infections including administering an effective subtoxic dosage of melittin (Seq. ID NO:1) to the mammal whereby the growth of HIV infected cells or the replication of the virus in the infected cells of the mammal is inhibited.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.